US Cancer Death Rates on the Decline, but Urban/Rural Divide Persists
Cancer death rates have declined in the United States in recent years, but the declines are greater in urban than in rural areas, data suggest.
Cancer death rates have declined in the United States in recent years, but the declines are greater in urban than in rural areas, data suggest.
A cancer patient’s race, type of insurance, and setting in which they are treated are all associated with end-of-life treatment, a study suggests.
Deaths in patients with COVID-19 and cancer made up 81% of excess deaths among cancer patients during the first 2 years of the pandemic.
EBRT plus brachytherapy does not improve outcomes over brachytherapy alone in patients with intermediate-risk prostate cancer, a phase 3 trial suggests.
Asian patients with de novo metastatic prostate cancer have better survival outcomes than White patients with the disease, according to a new study.
Atezolizumab, given with or without radiotherapy, has demonstrated some activity in a subset of patients with penile cancer.
Black and Hispanic patients have a higher risk of death from second primary cancers than White and Asian/Pacific Islander patients, new data suggest.
Researchers looked at the use of 6 biosimilars across 38 oncology practices and found that biosimilar use increased from 2019 to 2021.
Research has revealed regional disparities in outcomes for patients who are hospitalized with chemotherapy-related febrile neutropenia in the United States.
Critically ill patients with cancer who develop delirium have a higher risk of dying in the hospital or intensive care unit, a study suggests.